We retrospectively evaluated three fluent asthmatic children who developed speech dysfluency following administration of theophylline. The dysfluency ceased in all three, following discontinuation of the medication. The medication was re-instituted in two patients, prompting return of dysfluency. It is unknown whether the patients had characteristics of “acquired stuttering” or “developmental stuttering.” We urge appropriate testing should this complication again occur. This might then provide pharmacologic information regarding stuttering.
Get full access to this article
View all access options for this article.
References
1.
BloodsteinO.A Handbook on Stuttering.Chicago, The National Easter Seal Society, 1987, p. 1–126.
2.
PorfertA.R., RosenfieldD.B.Prevalence of stuttering. J Neurol Neurosury Psychiatry1978; 41: 954–956.
3.
RosenfieldD.B., VaswanathN.S., Callis-LandrumL. In PetersH.F.M., HulstijnW., StarkweatherC.W., eds. Speech Motor Control in Stuttering, Amsterdam, Excerpta Medica, 1991, p. 277–284.
4.
ArdilaA., LopezM.Stuttering associated with right hemisphere lesion. Brain and Lang1986; 27: 239–246.
5.
BaratzR., MesulamM.Adult-onset stuttering treated with anticonvulsants. Arch Neur1981; 38: 132.
6.
FleetW., HeilmanD.Acquired stuttering from a right hemisphere lesion in a right-handed. Neurol1985; 35: 1343–1346.
RosenbeckJ., MessertB., CollinsM.Stuttering following brain damage. Brain and Lang1978; 6: 82–96.
16.
RosenfieldD.B.Stuttering and cerebral ischemia. New Engl J Med1972; 287: 991.
17.
RosenfieldD.B., MillerSd, FeltovichM.F.Brain damage causes stuttering. Trans Am Neurol Assn1981; 105: 181–183.
18.
SchtremelA.Stutter in the left parietal syndrome. Z Hurnal Nevropatologii: Psikhiatrii Imeni SS Korsakova1963; 63: 828–832.
19.
McCarthyM.M.Speech effect of theophylline. Pediatrics1981; 68: 749–750.
20.
NudelmanH.B., HerbrichK.E., HoytB.D.Dynamic Characteristics of Vocal Frequency Tracking in Stutterers and Nonstutterers. In: PetersH.F.M., HulstijnW., eds. Speech Motor Dynamics in Stuttering.Wein: Springer-Verlag, 1987, p 167–169.
21.
NudelmanH.B., HerbrichK.E., HoytB.D.A neuroscience model of stuttering. J Fluency Disord1989; 14: 399–427.
22.
NudelmanH.B., HerbrichK.E., HoytB.D.A neuroscience approach to stuttering. In: PetersH.F.M., HulstignW., StarkweatherC.W., eds. Speech Motor Control in Stuttering.Elsevier, 1991; 157–162.
23.
NudelmanH.B., HerbrichK.E., HoytB.D.Phonatory response times of stutterers and fluent speakers to frequency-modulated tones. J Acoust Soc Am1992; 92: 1882–1888.
24.
RallT.W.Central nervous system stimulants-the methylxanthines. In: GilmanA.G., GoodmanL.S., RallT.W., eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 7th ed, 1985: 589–603.
